Importantly, experiments with a murine model for pulmonary fungal infection and fungal vulvovaginitis further proved the safety in vivo for PAF (Palicz et al., 2013, 2016) and NFAP2 (Kovács et al., 2019), respectively. Here, PCLAF is linked to fungal lung infectious disease.